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Treatment	 Antibody	 Cell	line	 First	Isoform	 Second	Isoform	
DMSO	 DNMT1	 MCF7	 1.00	 1.00	
1uM	AZA	 DNMT1	 MCF7	 0.39	 0.64	
6uM	DS	 DNMT1	 MCF7	 0.78	 0.72	
3uM	DS	 DNMT1	 MCF7	 1.04	 1.00	
DMSO	 DNMT1	 MDAMB231	 1.00	 1.00	
1uM	AZA	 DNMT1	 MDAMB231	 0.68	 1.07	
3uM	DS	 DNMT1	 MDAMB231	 0.47	 1.41			
Table	2:	Relative	intensity	ratios	of	DNMT1	protein	bands	for	Western	blot	2.		
Treatment	 Antibody	 Cell	line	 First	Isoform	 Second	Isoform	
DMSO		 DNMT1	 MCF7	 1.00	 1.00	
1uM	AZA	 DNMT1	 MCF7	 0.21	 0.76	
6uM	DS	 DNMT1	 MCF7	 0.51	 0.90	
3uM	DS	 DNMT1	 MCF7	 0.54	 1.00	
DMSO	 DNMT1	 MDAMB231	 1.00	 1.00	
1uM	AZA	 DNMT1	 MDAMB231	 0.63	 1.13	
6uM	DS	 DNMT1	 MDAMB231	 0.70	 1.21	






Figure 6 demonstrates that DS and AZA were much more effective in decreasing 
the protein expression of the first DNMT1 isoform in both the MCF-7 and MDA-MB-
231 cell lines. Protein expression for both DNMT1 isoforms exhibited a dose dependent 
response to DS in the MCF-7 cells. AZA was also able to decrease the protein expression 
of the first isoform of DNMT1 by 70% and the second isoform of DNMT1 by 30%. 
Protein expression in the MDA-MB-231 cells did not exhibit a dose dependent response 
to DS. DS and AZA were able to decrease protein expression of the first isoform of 
DNMT1 in the MDA-MB-231 cells, but they actually increased protein expression of the 

















AZA	1uM	 70%	decrease	 30%	decrease	 34%	decrease	 10%	increase	
DS	3uM	 21%	decrease	 no	decrease	 30%	decrease	 26%	increase	
DS	6uM	 36%	decrease	 19%	decrease	 42%	decrease	 21%	increase																																		
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Discussion	
	
	
	 The	present	study	was	focused	on	the	steroidal	saponin,	dioscin,	and	its		efficacy	as	a	DNMT1	inhibitor.	The	results	obtained	from	the	two	Western	blot	experiments	are	not	perfect,	but	they	are	promising.	DS	was	able	to	inhibit	the	protein	expression	of	both	isoforms	of	DNMT1	in	MCF-7	cells	and	the	protein	expression	of	the	first	isoform	(145	kDa)	of	DNMT1	in	MDA-MB-231	cells.	DS	and	AZA	exhibited	similar	effects	on	the	DNMT1	protein	concentration,	as	we	hoped	they	would.	These	complementary	results	reinforce	our	hypothesis	that	DS	is	a	potential	DNMT1	inhibitor.	It	can	also	be	concluded	that	DS	is	acting	post-transcriptionally	to	inhibit	DNMT1	protein	expression.	We	know	this	because	the	mRNA	content	of	DNMT1	in	MCF-7	and	MDA-MB-231	cells	remained	unaltered	when	treated	with	DS	(Aumsuwan	et	al.	2016).	Therefore,	DS	may	be	acting	on	the	DNMT1	mRNA	and	inhibiting	some	step	of	translation,	or	DS	may	be	directly	degrading	the	DNMT1	protein	with	a	mechanism	similar	to	AZA’s.			 While	these	results	support	our	hypothesis	that	DS	is	a	DNMT1	inhibitor,	there	are	still	some	questions	that	remain.	DS	was	able	to	inhibit	DNMT1	protein	expression	in	the	MCF-7	cells;	this	was	not	expected	considering	that	in	a	previously	conducted	experiment,	DS	increased	GATA3	and	CDH1	mRNA	expression	in	the	MDA-MB-231	cells	but	not	in	the	MCF-7	cells	(Aumsuwan	et	al.	2016).	For	this	reason,	DS’s	inhibition	of	DNMT1	may	not	be	the	only	contributing	factor	in	the	re-
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expression	of	GATA3	and	CDH1.	Analysis	of	DS’s	effect	on	other	epigenetic	proteins	may	be	needed	in	order	to	explain	the	exact	mechanism	by	which	DS	is	able	to	re-express	these	tumor	suppressor	genes.			 DS	is	a	proven	anti-breast	cancer	agent	in	vitro.	It	is	able	to	reduce	cell	proliferation	and	increase	expression	of	crucial	tumor	suppressor	genes.	Whether	or	not	DS’s	anti-breast	cancer	potential	stems	solely	from	its	DNMT1	inhibiting	activity	remains	to	be	seen,	but	there	is	a	clear	path	to	follow	in	order	to	determine	this.	The	effect	of	DS	on	other	epigenetic	proteins	involved	in	methylation	and	demethylation	must	be	determined.	DS’s	impact	on	DNMT3A	and	DNMT3B	protein	expression	should	be	examined,	as	well	as	its	impact	on	other	DNMT	binding	proteins	and	the	recently	discovered	TET	enzymes.	As	our	knowledge	in	the	field	of	epigenetics	increases,	so	will	our	knowledge	on	epigenetic	mechanisms	and	drug	treatments.	DS	may	one	day	be	used	as	an	anti-invasive	therapeutic	in	the	treatment	of	breast	cancer,	but	we	have	yet	to	elucidate	the	exact	mechanism	of	action	or	how	it	will	perform	in	an	animal	model.	For	now,	DS	is	a	promising	and	natural	anti-cancer	agent	with	the	potential	to	limit	DNMT1	protein	expression,	and	therefore	methylation,	in	breast	cancer	cells	in	vitro.		 	
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